000097483 001__ 97483
000097483 005__ 20220908120501.0
000097483 0247_ $$2doi$$a10.1016/j.ad.2020.11.006
000097483 0248_ $$2sideral$$a121664
000097483 037__ $$aART-2021-121664
000097483 041__ $$aspa
000097483 100__ $$aAbarca Lachén, E.
000097483 245__ $$aRevisión de las fórmulas magistrales (medicamentos individualizados) de mayor interés en dermatología pediátrica
000097483 260__ $$c2021
000097483 5060_ $$aAccess copy available to the general public$$fUnrestricted
000097483 5203_ $$aThe administration of appropriate doses of active ingredients and excipients is crucial for achieving desired treatment outcomes in pediatric dermatology. A number of factors need to be considered, including the characteristics of the lesion, the patient, and the drug. An additional challenge in pediatric settings is the limited number of commercially available formulations suitable for use in children. Drug compounding, which is the preparation of medications tailored to the needs of individual patients, is a good alternative for pediatric populations for a number of reasons. Using a customized compound, the clinician can prescribe formulations that contain the optimal dose of the active ingredients within acceptable limits and the most suitable vehicle and formulation components. Compounding can also be used to combine several active ingredients in a single medication and even adapt the vehicle to the characteristics of the lesion and the needs of the patient. The pharmaceutical formulations described in this review are based on extensive clinical experience and can be customized to meet individual needs. is the preparation of medications tailored to the needs of individual patients, is a good alternative for pediatric populations for a number of reasons. Using a customized compound, the clinician can prescribe formulations that contain the optimal dose of the active ingredients within acceptable limits and the most suitable vehicle and formulation components. Compounding can also be used to combine several active ingredients in a single medication and even adapt the vehicle to the characteristics of the lesion and the needs of the patient. The pharmaceutical formulations described in this review are based on extensive clinical experience and can be customized to meet individual needs.
000097483 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
000097483 592__ $$a0.279$$b2021
000097483 593__ $$aPathology and Forensic Medicine$$c2021$$dQ3
000097483 593__ $$aDermatology$$c2021$$dQ3
000097483 594__ $$a1.2$$b2021
000097483 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000097483 700__ $$aHernando Martínez, P.
000097483 700__ $$0(orcid)0000-0001-8034-3617$$aGilaberte Calzada, Y.$$uUniversidad de Zaragoza
000097483 7102_ $$11007$$2183$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cÁrea Dermatología
000097483 773__ $$g112, 4 (2021), 302-313$$pActas dermo-sifiliogr.$$tActas Dermo-Sifiliograficas$$x0001-7310
000097483 8564_ $$s413039$$uhttps://zaguan.unizar.es/record/97483/files/texto_completo.pdf$$yVersión publicada
000097483 8564_ $$s63179$$uhttps://zaguan.unizar.es/record/97483/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000097483 909CO $$ooai:zaguan.unizar.es:97483$$particulos$$pdriver
000097483 951__ $$a2022-09-08-11:54:17
000097483 980__ $$aARTICLE